BofA upgraded Amylyx (AMLX) to Buy from Neutral with a $10 price target Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on AMLX: Amylyx announces HELIOS clinical trial meets primary endpoint Amylyx Pharmaceuticals Navigates Shift to Smaller Reporting Status: Impacts on Investor Relations and Stock Volatility Amylyx CFO buys $101.4K in common stock Largest borrow rate increases among liquid names